Observation on sensitivity of human gastric cancer SGC-7901 cells to cisplatin by RNAi techniques

CUI Ying,SHI Jian-guo,ZANG Dan-dan,YANG Shi-ming,YAN Qing-guo
2009-01-01
Abstract:Objective: In our study,we investigated whether down-regulating Rb protein by RNAi techniques can enhance the sensitivity of human gastric cancer SGC-7901 cells to cisplatin. Methods: SiRNA targeting Rb or the negative control siRNA was transfected into SGC-7901 cells. Efficiency of knockdown was tested by RT-PCR and Western blot. Cell cycle distribution was analyzed by FACS. Cells with siRNA transfection were cultured in 10% FBS or serum free medium and were treated with cisplatin for different periods. Apoptosis was analyzed by activated caspase-3. Cell survival was analyzed by MTT assay. Results: An siRNA targeting Rb significantly decreased the protein and RNA level, which released the cells from G1 phase. Treatment of these cells with 20 μM cisplatin increased apoptotic cell death approximately 1.8-fold compared to cells transfected with negative control siRNA when cells were cultured in 10% serum. In contrast, cells cultured in the serum free medium have no significant differences between Rb inhibition and the control. Conclusions: Our data demonstrate that down-regulation of Rb using RNAi techniques enhances the chemosensitivity of gastric cancer cells to cisplatin through facilitating cells enter the G1 phase.
What problem does this paper attempt to address?